AptarGroup : Aptar Chairman King Harris to Retire, George Fotiades Appointed S...
January 22, 2018 at 06:29 pm
Share
After 40 years of insightful guidance and dedicated oversight, Aptar Chairman of the Board King Harris will retire, effective May 2, 2018. Mr. Harris oversaw Aptar's predecessor businesses when they were part of Pittway Corporation where he played a critical role in fostering the original vision for Aptar. He has served on Aptar's Board since it became a stand-alone public company in 1993 and was appointed Chairman of the Board in 1995.
His tireless leadership nurtured new thinking and shaped Aptar into a leading provider of dispensing and drug delivery solutions. He leaves an important legacy at Aptar that will continue to play a role in cultivating a company culture of success and innovation.
Aptar's Board of Directors has elected current director, George Fotiades, to replace Mr. Harris upon his retirement. A member of the company's Board since 2011, Mr. Fotiades is an accomplished leader, having previously served as president and chief operating officer of Cardinal Health, Inc., and in various leadership positions at Fortune 500 companies, including Bristol-Myers Squibb and Procter & Gamble.
With a deep understanding of Aptar's strategy, markets and competitive advantages, Mr. Fotiades has been a valued member of the Board and is well-positioned for the role of Chairman.
In the coming months, Mr. Harris and Mr. Fotiades, along with the rest of the Board, will work together to ensure a seamless transition. The Board is grateful for Mr. Hariss' valued leadership and looks forward to continued success under Mr. Fotiades' direction.
Click here to download the full press release, or email newsroom@aptar.com for more information.
(Photo: L - Mr. King Harris; R - Mr. George Fotiades)
AptarGroup Inc. published this content on 22 January 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 22 January 2018 18:29:09 UTC.
Original documenthttp://news.aptar.com/financial-news/aptar-chairman-king-harris-to-retire-george-fotiades-appointed-successor/
Public permalinkhttp://www.publicnow.com/view/37EE487ACB861CE16D1F2C6007DA0AC5DDE9770A
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
APTARGROUP, INC. 
